Differential Retinoic Acid Signaling in Tumors of Long- and Short-term Glioblastoma Survivors

Abstract excerpt

Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-term survival of 36 months or longer after diagnosis. To study the differences in activation of biochemical pathways, we performed mRNA and protein expression analyses of primary glioblastoma tissues from 11 long-term survivors (LTS; overall survival ≥ 36 months) and 12 short-term survivors (STS; overall survival ≤ 6 months)....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glioma Diagnosis and Treatment
• Share to Peroxisome Proliferator-Activated Receptors
• Share to Retinoids in leukemia and cellular processes